Continued open discussion on these new technologies are essential moving forward so that consumers can be familiar with ...
Don't you think that the cost of not doing it is important, as well?
Sure. And, you know, and of course we want the aid to get there regardless of where it comes from, right? You want peopl...
I would hate to see the work of this Congress and, you know, the chairman, I know, has worked on these issues a lot--I w...
More work lies ahead, but great strides have been made.
I think I have heard it said more than once today on the panel in front of us the words 'alleviate suffering'.
It is vital that the Food and Drug Administration routinely incorporate the patient perspective in its decisionmaking pr...
But, make no mistake about it, we are getting our work done.
This is a good thing because it will get safe and effective products to doctors and to patients faster.
Thank you for your leadership. You have done great work.
I want to thank the FDA and the industry and patient advocates and providers and other stakeholders for their work on th...
Reauthorizing the Medical Device User Fee Agreements and the user fee programs we have previously discussed would increa...
This is a good agreement that will build upon some recent successes.
Let's continue to build upon these remarkable and bipartisan advancements that put patients first.
Now is the time for Members of Congress--regardless of party--to stand together in support of a non-partisan commission.
The Department of Justice did conclude that they should abandon, to the extent possible, the term 'reasonable scientific...
We need to ensure that our Federal departments and agencies are properly defended from attacks; we do NOT have time to w...
I guess I want to start and ask your opinion on that report: whether you think it has the scientific rigor, if you will,...
